Eastar Industries, focuses on Eastar's pharmaceutical and health/beauty business for China and selected Southeast Asian countries. Eastar Industries licenses patented pharmaceuticals, medical devices and unique health/beauty products from U.S. and European companies for import to China and Southeast Asia through its local joint venture partner companies.

"This joint venture with Eastar Industries is an important step in AirWare's mission to help people live healthier lives through better breathing," said Jeffrey Rassás, CEO of AirWare Labs. "Residents of China are struggling with life-threatening air pollution that impacts their health on a daily basis. AirWare's filtered nasal products are an effective and discreet alternative to the face masks many wear to combat the negative effects of polluted air."

Designed with an integrated filter media from 3M, AirWare's nasal inserts trap airborne contaminants and prevent them from entering the body through the nasal passage. The filter protects wearers from up to 90% of common particulates, 75% or more of airborne viruses, and 92% or more of plant spores and airborne pollens. Face masks, which are widely used throughout China, do not provide a complete seal against contaminants and force wearers to breathe in their own exhaled carbon dioxide.

"Residents of China are very concerned about airborne viruses, air quality and their impact on health," said Tony Chu, CEO of Eastar Industries. "AirWare's filtered nasal products provide a great solution for hundreds of millions of people looking for a way to protect themselves and their families."

Click here for the complete issue.